Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on August 28, 2007
JNCI Journal of the National Cancer Institute 2007 99(17):1346-1347; doi:10.1093/jnci/djm094
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/17/1346    most recent
djm094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cascinu, S.
Right arrow Articles by Frontini, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cascinu, S.
Right arrow Articles by Frontini, L.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

Stefano Cascinu, Mario Scartozzi, Carlo Barone, Roberto Labianca, Armando Santoro, Carlo Carnaghi, Giordano D. Beretta, Vincenzo Catalano, Sandro Barni, Luciano Frontini

Affiliations of authors: Clinica di Oncologia Medica, Universita' Politecnica delle Marche, Ancona, Italy (SC, MS); Oncologia Medica, Universita' Cattolica del Sacro Cuore, Policlinico A. Gemelli, Roma, Italy (CB); Oncologia Medica, Azienda Ospedaliera "Ospedali Riuniti di Bergamo," Bergamo, Italy (RL, GDB); Oncologia Medica, Istituto Clinico Humanitas, Milano, Italy (AS, CC); Oncologia Medica, Azienda Ospedaliera S. Salvatore, Pesaro, Italy (VC); Oncologia Medica, Azienda Ospedaliera di Treviglio, Treviglio, Bergamo, Italy (SB); Clinical Trials Unit, GISCAD, Milano, Italy (LF)

Correspondence to: Stefano Cascinu, MD, Clinica di Oncologia Medica, Universita' Politecnica delle Marche, Ospedali Riuniti di Ancona. Via Conca, 60020 Ancona, Italy (e-mail: cascinu@yahoo.com).

The first 10% of the full text of this article appears below.

We have read with interest the correspondence regarding the role of pre- and postoperative chemotherapy in gastric cancer in response to our recent report of an intensive adjuvant chemotherapy in gastric cancer (1). The idea that preoperative chemotherapy may be a more suitable treatment approach . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial
Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, Katia Lorizzo, Maria Giulia Zampino, Filippo de Braud, Antonio Chiappa, Arnaud Roth, and Aron Goldhirsch
J Natl Cancer Inst 2007 99: 1345-1346. [Extract] [Full Text] [PDF]